Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Chief: Doctors Can Make Own Decisions About Hydroxychloroquine
Stephen Hahn, the commissioner of the Food and Drug Administration (FDA), on Thursday declined to take a definitive stance on聽whether people should take hydroxychloroquine as a treatment for the coronavirus, instead saying that decision should be made between a doctor and a patient. 鈥淲e had data that when this drug was combined with others, there was some risk associated with that. But the question you鈥檙e asking me is a decision between a doctor and a patient,鈥 Hahn said on NBC鈥檚 鈥淭oday鈥 show.聽(Axelrod, 7/30)
Researchers on Wednesday published scathing critiques of a study President Trump repeatedly touted on Twitter. That study, published earlier this month in the International Journal of Infectious Diseases, claimed to show that hydroxychloroquine saved lives. President Trump tweeted about it enthusiastically. (Cohen, 7/31)
Kaiser Health News and Politifact HealthCheck: Don鈥檛 Fall For This Video: Hydroxychloroquine Is Not A COVID-19 Cure聽
Millions of people,聽including the president聽of the United States, have seen or shared a video in which a doctor falsely claims there is a cure for the coronavirus, and it鈥檚 a medley starring hydroxychloroquine. The video shows several doctors in white coats giving a press conference outside the Supreme Court in Washington, D.C. It聽persists聽on social media聽despite bans聽from Facebook, Twitter and YouTube, and it was published by Breitbart, a conservative news site. (Funke, 7/31)
Also 鈥
The State of Ohio Board of Pharmacy聽on Thursday withdrew a rule that would have barred聽pharmacists, licensed distributors of drugs and medical institutions from prescribing the controversial anti-malaria drug hydroxychloroquine to treat or prevent the novel coronavirus聽after Gov. Mike DeWine (R) voiced concerns.聽The state pharmacy聽board said in a memo on Wednesday that the rule would, in general, prohibit the use of hydroxychloroquine and chloroquine for the treatment or prevention of COVID-19... But the rule quickly met with pushback from DeWine (R), who urged the state board to reconsider the decision the day it went into effect. (Wise, 7/30)